Journals / MN Oftalmoloji / 2020 / Cilt: 27 - Sayı: 3

The Effect of Ophthalmopaty on Quality of Life in Autoimmune Thyroid Diseases

Otoimmün Tiroid Hastalıklarında Oftalmopatinin Yaşam Kalitesi Üzerine Etkisi

Pages
121–126
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Furthermore, quality of life decreases as the grade and duration of thyroid ophthalmopathy increase.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate quality of life in patients with thyroid ophthalmopathy and also to determine the relation between quality of life and grade and duration of thyroid ophthalmopathy.
📊
Key Findings & Data:Short Form-36 (SF-36) questionnaire was performed to both study and control groups in order to evaluate effect of thyroid ophthalmopathy on quality of life.
💡
Conclusion & Impact:Furthermore, quality of life decreases as the grade and duration of thyroid ophthalmopathy increase.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate quality of life in patients with thyroid ophthalmopathy and also to determine the relation between quality of life and grade and duration of thyroid ophthalmopathy. Material and Method: Eighty patients with thyroid ophthalmopathy and a control group with eighty subjects were prospectively evaluated. The diagnosis and grading of thyroid ophthalmopathy were performed by European Group on Graves’ Orbitopathy classification. Following examinations were performed to all subjects, best corrected visual acuity, color vision, light reflex, anterior segment, fundus, intraorbital pressure, Hertel exophthalmometry and orthoptic examination. Short Form-36 (SF-36) questionnaire was performed to both study and control groups in order to evaluate effect of thyroid ophthalmopathy on quality of life. Results: All parameters of SF-36 questionnaire in ophthamopathy group were significantly decreased compared to those in control group (p<0.05). The scores of general health perception (p=0.032), physical role restriction (p=0.024), physical function (p=0.004), pain (p=0.041) and mental health (p=0.078) were significantly decreased as the grade of thyroid ophthalmopathy increased. Patients with a duration of thyroid ophthamopathy ≥1 year have significant reductions in the scores of general health perception (p<0.001), physical role restriction (p=0.005), physical function (p=0.004), pain (p=0.023) and emotional role restriction (p=0.025) compared to those with a duration of <1 year. There was a negative significant correlation between duration of thyroid ophthalmopathy and all parameters of SF-36 questionnaire (p<0.05). Conclusion: Thyroid ophthalmopathy has a significant negative effect on quality of life. Furthermore, quality of life decreases as the grade and duration of thyroid ophthalmopathy increase.

Özet

Amaç: Tiroid oftalmopatisi olan hastaların yaşam kalitesini değerlendirmek ve aynı zamanda tiroid oftalmopatinin evresi ve süresi ile yaşam kalitesi arasındaki ilişkiyi belirlemek. Gereç ve Yöntem: Tiroid oftalmopati tanısı alan 80 hasta ve oftalmolojik hastalığı olmayan 80 kişilik bir kontrol grubu prospektif olarak değerlendirildi. Tiroid oftalmopatinin tanısı ve evrelemesi European Group on Graves’ Orbitopathy sınıflandırmasına göre yapıldı. Tüm olguların düzeltilmiş en iyi görme keskinliği ölçümü, renkli görme ölçümü, ışık refleksi değerlendirmesi, ön segment muayenesi, fundus muayenesi, göz içi basıncı ölçümü, Hertel ekzoftalmometre ile proptozis ölçümü ve ortoptik muayenesi yapıldı. Tüm hastalara tiroid oftalmopatinin yaşam kalitesi üzerine olan etkisini belirlemek amacıyla hem çalışma hem de kontrol grubuna Short Form-36 (SF-36) ölçeği uygulandı. Bulgular: Oftalmopati grubunun SF-36 ölçeğine ait tüm parametrelerinin skorları kontrol grubuna göre istatistiksel olarak anlamlı derecede daha düşüktü (p<0,05). Oftalmopatinin şiddeti arttıkça genel sağlık algısı (p=0,032), fiziksel rol kısıtlılığı (p=0,024), fiziksel fonksiyon (p=0,004), ağrı (p=0,041) ve mental sağlık (p=0,078) parametrelerinin skorları istatistiksel olarak anlamlı derecede azalmakta idi. Tiroid oftalmopatisi 1 yıl ve daha fazla süre devam eden hastaların genel sağlık algısı (p<0,001), fiziksel rol kısıtlılığı (p=0,005), fiziksel fonksiyon (p=0.004), ağrı (p=0,023) ve emosyonel rol kısıtlılığı (p=0,025) tiroid oftalmopatisi 1 yıldan daha az devam eden hastalara göre anlamlı derecede daha düşüktü. Tiroid oftalmopatinin süresi ile SF-36 ölçeğinin tüm parametreleri arasında istatistiksel olarak anlamlı derecede negatif korelasyon mevcuttu (p<0,05). Sonuç: Tiroid oftalmopati yaşam kalitesini önemli ölçüde olumsuz yönde etkilemektedir. Bununla birlikte, tiroid oftalmopatinin şiddeti ve süresi arttıkça yaşam kalitesi azalmaktadır.

🔖

Cite This Article

EKİN, M. A. (2020). The Effect of Ophthalmopaty on Quality of Life in Autoimmune Thyroid Diseases. MN Oftalmoloji, Cilt: 27 - Sayı: 3, 121–126. https://ajindex.com/articles/295324

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Şahlı E. Gündüz K. Tiroid oftalmopati. Turk J Ophthalmol 2017;47(2):94-105
  2. Ponto KA. Binder H. Diana T. et al. Prevalence, phenotype, and psychosocial well-being in euthyroid/hypothyroid thyroid-associated orbitopathy. Thyroid. 2015;25(8):942-8
  3. Li Z. Cestari DM. Fortin E. Thyroid eye disease: what is new to know? Curr Opin Ophthalmol. 2018;29(6):528-34
  4. Terwee C. Wakelkamp I. Tan S. Dekker F. Prummel MF. Wiersinga W. Long-term effects of Graves’ ophthalmopathy on health-related quality of life. Eur J Endocrinol. 2002;146(6):751- 7
  5. Wiersinga WM. Prummel MF. Terwee CB. Effects of Graves’ ophthalmopathy in quality of life. J Endocrinol Invest. 2004;27(3):259-64
  6. Kahaly GJ. Petrak F. Hardt J. Pitz S. Egle UT. Psychosocial morbidity of Graves’ orbitopathy. Clin Endocrinol. 2005;63(4):395- 402
  7. Lee Hun. Roh HS. Yoon JS. Lee SY. Assessment of quality of life and depression in Korean patients with Graves’ ophthalmopathy. Korean J Ophthalmol. 2010;24(2):65-72
  8. Prummel MF. Bakker A. Wiersinga WM. et al. Multi-center study on the characteristics and treatment strategies of patients with Graves’ orbitopathy: the first European group on Graves’ orbito - pathy experience. Eur J Endocrin. 2003;148(5):491-5
  9. Jenkinson C. Coulter A. Wright L. Short Form 36 (SF 36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306(6890):1437-40
  10. Koçyiğit H. Aydemir Ö. Fişek G. Kısa Form-36'nın Türkçe versiyonunun güvenilirliği ve geçerliliği. İlaç Tedavi Derg. 1999;12(2):102-6
  11. Martin LM., Sheridan MJ. Younossi ZM. The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep. 2002;4(1):79-83
  12. Quittner AL. Marciel KK. Salathe MA. et al. A preliminary quality of life questionnaire-bronchiectasis: a patient reported outcome measure for bronchiectasis. Chest. 2014;146(2):437-48
  13. Paik JS. Yang SW. Evaluaiton of mood disturbance in Korean patients with dysthyroid ophthalmopathy. J Korean Ophthalmol Soc. 2009;50(9):1301-7
  14. Huang Y. Fang S. Li D. Zhou H. Li B. Fan X. The involvement of T cell pathogenesisin thyroid-associated ophthalmopathy. Eye. 2019;33(2):176-82
  15. Gerding MN. Terwee CB. Dekker FW. Koornneef L. Prummel MF. Wiersinga WM. Quality of life in patients with Graves’ ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid. 1997;7(6):885-9.